clinical trial · NCT07389031

Maralixibat for Intrahepatic Cholestasis of Pregnancy

Imperial College London·phase2·not yet recruiting·n = 28

Intrahepatic Cholestasis of PregnancyMaralixibat

brief summary

An open label phase 2a/b trial of maralixibat in patients with Intrahepatic Cholestasis of Pregnancy (ICP) and elevated serum bile acid concentrations (sBA) to evaluate safety and tolerability

started

Apr 1, 2026

primary completion

Mar 31, 2028

completion

Mar 31, 2028

last updated

Feb 5, 2026

official title

Maralixibat for the trEatment of inTrAhePatic cHOlestasis of pRegnancy (METAPHOR)

full record on clinicaltrials.gov ↗

sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol